Arlt Volker M, Zhan Li, Schmeiser Heinz H, Honma Masamitsu, Hayashi Makoto, Phillips David H, Suzuki Takayoshi
Section of Molecular Carcinogenesis, Institute of Cancer Research, Surrey, United Kingdom.
Environ Mol Mutagen. 2004;43(3):186-95. doi: 10.1002/em.20014.
3-nitrobenzanthrone (3-NBA) is an extremely potent mutagen in the Salmonella reversion assay and a suspected human carcinogen identified in diesel exhaust and in ambient airborne particulate matter. To evaluate the in vivo mutagenicity of 3-NBA, we analyzed the mutant frequency (MF) in the cII gene of various organs (lung, liver, kidney, bladder, colon, spleen, and testis) in lambda/lacZ transgenic mice (Muta Mouse) after intraperitoneal treatment with 3-NBA (25 mg/kg body weight injected once a week for 4 weeks). Increases in MF were found in colon, liver, and bladder, with 7.0-, 4.8-, and 4.1-fold increases above the control value, respectively, whereas no increase in MF was found in lung, kidney, spleen, and testis. Simultaneously, induction of micronuclei in peripheral blood reticulocytes was observed. The sequence alterations in the cII gene recovered from 41 liver mutants from 3-NBA-treated mice were compared with 32 spontaneous mutants from untreated mice. Base substitution mutations predominated for both the 3-NBA-treated (80%) and the untreated (81%) groups. However, the proportion of G:C-->T:A transversions in the mutants from 3-NBA-treated mice was higher (49% vs. 6%) and the proportion of G:C-->A:T transitions was lower than those from untreated mice (10% vs. 66%). The increase in MF in the liver was associated with strong DNA binding by 3-NBA, whereas in lung, in which there was no increase in MF, a low level of DNA binding was observed (268.0-282.7 vs. 8.8-15.9 adducts per 10(8) nucleotides). DNA adduct patterns with multiple adduct spots, qualitatively similar to those formed in vitro after activation of 3-NBA with nitroreductases and in vivo in rats, were observed in all tissues examined. Using high-pressure liquid cochromatographic analysis, we confirmed that all major 3-NBA-DNA adducts produced in vivo in mice are derived from reductive metabolites bound to purine bases (70-80% with deoxyguanosine and 20-30% with deoxyadenosine in liver). These results suggest that G:C-->T:A transversions induced by 3-NBA are caused by misreplication of adducted guanine residues through incorporation of adenine opposite the adduct (A-rule).
3-硝基苯并蒽酮(3-NBA)在沙门氏菌回复突变试验中是一种极强的诱变剂,也是在柴油废气和环境空气中颗粒物中鉴定出的疑似人类致癌物。为了评估3-NBA的体内诱变性,我们分析了λ/lacZ转基因小鼠(Muta Mouse)经腹腔注射3-NBA(25mg/kg体重,每周注射一次,共4周)后,各器官(肺、肝、肾、膀胱、结肠、脾和睾丸)cII基因中的突变频率(MF)。在结肠、肝和膀胱中发现MF增加,分别比对照值增加了7.0倍、4.8倍和4.1倍,而在肺、肾、脾和睾丸中未发现MF增加。同时,观察到外周血网织红细胞中微核的诱导。将从3-NBA处理小鼠的41个肝突变体中回收的cII基因序列改变与未处理小鼠的32个自发突变体进行比较。在3-NBA处理组(80%)和未处理组(81%)中,碱基替换突变均占主导。然而,3-NBA处理小鼠的突变体中G:C→T:A颠换的比例更高(49%对6%),G:C→A:T转换的比例低于未处理小鼠(10%对66%)。肝脏中MF的增加与3-NBA强烈的DNA结合有关,而在MF未增加的肺中,观察到低水平的DNA结合(每10^8个核苷酸中加合物分别为268.0 - 282.7个对8.8 - 15.9个)。在所有检测的组织中均观察到具有多个加合物斑点的DNA加合物模式,其在质量上与用硝基还原酶体外激活3-NBA后以及在大鼠体内形成的模式相似。通过高压液相共色谱分析,我们证实小鼠体内产生的所有主要3-NBA-DNA加合物均来自与嘌呤碱基结合 的还原代谢物(肝脏中70 - 80%与脱氧鸟苷结合,20 - 30%与脱氧腺苷结合)。这些结果表明,3-NBA诱导的G:C→T:A颠换是由加合鸟嘌呤残基通过与加合物相对掺入腺嘌呤而导致的错误复制(A规则)引起的。